KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Cash from Operations: 2009-2024

Historic Cash from Operations for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $417.5 million.

  • Chemed's Cash from Operations fell 787.58% to $83.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $287.5 million, marking a year-over-year decrease of 1472.71%. This contributed to the annual value of $417.5 million for FY2024, which is 2639.97% up from last year.
  • Per Chemed's latest filing, its Cash from Operations stood at $417.5 million for FY2024, which was up 2639.97% from $330.3 million recorded in FY2023.
  • In the past 5 years, Chemed's Cash from Operations registered a high of $489.3 million during FY2020, and its lowest value of $308.6 million during FY2021.
  • For the 5-year period, Chemed's Cash from Operations averaged around $371.1 million, with its median value being $330.3 million (2023).
  • In the last 5 years, Chemed's Cash from Operations surged by 6242.01% in 2020 and then plummeted by 3692.95% in 2021.
  • Annual analysis of 5 years shows Chemed's Cash from Operations stood at $489.3 million in 2020, then crashed by 36.93% to $308.6 million in 2021, then rose by 0.42% to $309.9 million in 2022, then grew by 6.59% to $330.3 million in 2023, then rose by 26.4% to $417.5 million in 2024.
  • Its Cash from Operations was $417.5 million in FY2024, compared to $330.3 million in FY2023 and $309.9 million in FY2022.